» Articles » PMID: 16818327

HIV Prevalence Among IDUs in Australia: a Methodological Review

Overview
Specialty Psychiatry
Date 1993 Jan 1
PMID 16818327
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

A review was carried out of Australian studies which have measured the prevalence of HIV infection among injecting drug users (IDUs). The review considered published studies which had reported on serologically-determined HIV prevalence. There were five studies reported from specialized sexually-transmissible disease of HIV clinics, five studies reported from health services aimed at IDUs, three studies reported from other health services and one multi-centre behavioural study. The main findings from the studies were that HIV prevalence in IDUs has been low in Australia, apart from in male IDUs who also had homosexual contact. HIV prevalence ranged from 20 to 24% in male IDUs reporting homosexual contact and from 0 to 5% in other IDUs.The studies, while reflecting a range of research methodologies, are subject to a number of limitations. Most of the studies did not provide detailed analyses of HIV prevalence by age and sex or behavioural factors, and several studies used sampling frames which were not clearly defined. There is little available information on temporal trends in seroprevalence and geographical comparisons are rendered difficult by differences in the study methodology. Adoption of standardized, continuing seroprevalence surveys on IDUs would provide a better means of monitoring the occurrence of HIV infection in this group, which has been a key determinant of the course of the HIV epidemic in a number of Western countries.

Citing Articles

Diffusion of the D.A.R.E and syringe exchange programs.

Des Jarlais D, Sloboda Z, Friedman S, Tempalski B, McKnight C, Braine N Am J Public Health. 2006; 96(8):1354-8.

PMID: 16809601 PMC: 1522095. DOI: 10.2105/AJPH.2004.060152.


Harm reduction: Australia as a case study.

Wodak A Bull N Y Acad Med. 1995; 72(2):339-47.

PMID: 10101374 PMC: 2359449.


Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.

van Beek I, Dwyer R, Dore G, Luo K, Kaldor J BMJ. 1998; 317(7156):433-7.

PMID: 9703523 PMC: 28635. DOI: 10.1136/bmj.317.7156.433.


Risk factors for hepatitis C virus infection among injecting drug users in Sydney.

van Beek I, Buckley R, Stewart M, MacDonald M, Kaldor J Genitourin Med. 1994; 70(5):321-4.

PMID: 8001943 PMC: 1195275. DOI: 10.1136/sti.70.5.321.


A national surveillance system for newly acquired HIV infection in Australia. National HIV Surveillance Committee.

McDonald A, Gertig D, Crofts N, Kaldor J Am J Public Health. 1994; 84(12):1923-8.

PMID: 7998631 PMC: 1615389. DOI: 10.2105/ajph.84.12.1923.